List of Tables
Table 1. Global Long-acting ESAs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Long-acting ESAs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Long-acting ESAs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Long-acting ESAs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Long-acting ESAs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Long-acting ESAs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Long-acting ESAs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Long-acting ESAs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Long-acting ESAs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Long-acting ESAs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Long-acting ESAs, Product Types and Applications
Table 12. Global Key Manufacturers of Long-acting ESAs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Long-acting ESAs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Long-acting ESAs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Long-acting ESAs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Long-acting ESAs Sales by Region (K Units), 2021–2026
Table 18. Global Long-acting ESAs Sales Market Share by Region (2021–2026)
Table 19. Global Long-acting ESAs Sales by Region (K Units), 2027–2032
Table 20. Global Long-acting ESAs Sales Market Share by Region (2027–2032)
Table 21. Global Long-acting ESAs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Long-acting ESAs Revenue Market Share by Region (2021–2026)
Table 23. Global Long-acting ESAs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Long-acting ESAs Revenue Market Share by Region (2027–2032)
Table 25. North America Long-acting ESAs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Long-acting ESAs Sales by Country (K Units), 2021–2026
Table 27. North America Long-acting ESAs Sales by Country (K Units), 2027–2032
Table 28. North America Long-acting ESAs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Long-acting ESAs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Long-acting ESAs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Long-acting ESAs Sales by Country (K Units), 2021–2026
Table 32. Europe Long-acting ESAs Sales by Country (K Units), 2027–2032
Table 33. Europe Long-acting ESAs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Long-acting ESAs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Long-acting ESAs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Long-acting ESAs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Long-acting ESAs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Long-acting ESAs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Long-acting ESAs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Long-acting ESAs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Long-acting ESAs Sales by Country (K Units), 2021–2026
Table 42. Latin America Long-acting ESAs Sales by Country (K Units), 2027–2032
Table 43. Latin America Long-acting ESAs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Long-acting ESAs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Long-acting ESAs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Long-acting ESAs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Long-acting ESAs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Long-acting ESAs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Long-acting ESAs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Long-acting ESAs Sales (K Units) by Type (2021–2026)
Table 51. Global Long-acting ESAs Sales (K Units) by Type (2027–2032)
Table 52. Global Long-acting ESAs Sales Market Share by Type (2021–2026)
Table 53. Global Long-acting ESAs Sales Market Share by Type (2027–2032)
Table 54. Global Long-acting ESAs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Long-acting ESAs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Long-acting ESAs Revenue Market Share by Type (2021–2026)
Table 57. Global Long-acting ESAs Revenue Market Share by Type (2027–2032)
Table 58. Global Long-acting ESAs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Long-acting ESAs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Long-acting ESAs Sales (K Units) by Application (2021–2026)
Table 61. Global Long-acting ESAs Sales (K Units) by Application (2027–2032)
Table 62. Global Long-acting ESAs Sales Market Share by Application (2021–2026)
Table 63. Global Long-acting ESAs Sales Market Share by Application (2027–2032)
Table 64. Global Long-acting ESAs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Long-acting ESAs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Long-acting ESAs Revenue Market Share by Application (2021–2026)
Table 67. Global Long-acting ESAs Revenue Market Share by Application (2027–2032)
Table 68. Global Long-acting ESAs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Long-acting ESAs Price (US$/Unit) by Application (2027–2032)
Table 70. Kyowa Kirin Company Information
Table 71. Kyowa Kirin Description and Business Overview
Table 72. Kyowa Kirin Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Kyowa Kirin Long-acting ESAs Product
Table 74. Kyowa Kirin Recent Developments/Updates
Table 75. Amgen Company Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Amgen Long-acting ESAs Product
Table 79. Amgen Recent Developments/Updates
Table 80. Dr. Reddy's Laboratories Company Information
Table 81. Dr. Reddy's Laboratories Description and Business Overview
Table 82. Dr. Reddy's Laboratories Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Dr. Reddy's Laboratories Long-acting ESAs Product
Table 84. Dr. Reddy's Laboratories Recent Developments/Updates
Table 85. Roche Company Information
Table 86. Roche Description and Business Overview
Table 87. Roche Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Roche Long-acting ESAs Product
Table 89. Roche Recent Developments/Updates
Table 90. Hansoh Pharma Company Information
Table 91. Hansoh Pharma Description and Business Overview
Table 92. Hansoh Pharma Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Hansoh Pharma Long-acting ESAs Product
Table 94. Hansoh Pharma Recent Developments/Updates
Table 95. Cipla Company Information
Table 96. Cipla Description and Business Overview
Table 97. Cipla Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Cipla Long-acting ESAs Product
Table 99. Cipla Recent Developments/Updates
Table 100. Sanwa Kagaku Kenkyusho Company Information
Table 101. Sanwa Kagaku Kenkyusho Description and Business Overview
Table 102. Sanwa Kagaku Kenkyusho Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Sanwa Kagaku Kenkyusho Long-acting ESAs Product
Table 104. Sanwa Kagaku Kenkyusho Recent Developments/Updates
Table 105. Kissei Pharmaceutical Company Information
Table 106. Kissei Pharmaceutical Description and Business Overview
Table 107. Kissei Pharmaceutical Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Kissei Pharmaceutical Long-acting ESAs Product
Table 109. Kissei Pharmaceutical Recent Developments/Updates
Table 110. Kyowa Hakko Kirin Company Information
Table 111. Kyowa Hakko Kirin Description and Business Overview
Table 112. Kyowa Hakko Kirin Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Kyowa Hakko Kirin Long-acting ESAs Product
Table 114. Kyowa Hakko Kirin Recent Developments/Updates
Table 115. Torrent Pharmaceuticals Company Information
Table 116. Torrent Pharmaceuticals Description and Business Overview
Table 117. Torrent Pharmaceuticals Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Torrent Pharmaceuticals Long-acting ESAs Product
Table 119. Torrent Pharmaceuticals Recent Developments/Updates
Table 120. CKD Pharma Company Information
Table 121. CKD Pharma Description and Business Overview
Table 122. CKD Pharma Long-acting ESAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. CKD Pharma Long-acting ESAs Product
Table 124. CKD Pharma Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Long-acting ESAs Distributors List
Table 128. Long-acting ESAs Customers List
Table 129. Long-acting ESAs Market Trends
Table 130. Long-acting ESAs Market Drivers
Table 131. Long-acting ESAs Market Challenges
Table 132. Long-acting ESAs Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Long-acting ESAs
Figure 2. Global Long-acting ESAs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Long-acting ESAs Market Share by Type: 2025 & 2032
Figure 4. Darbepoetin Alfa Product Picture
Figure 5. Methoxy Polyethylene Glycol-Epoetin Beta Product Picture
Figure 6. Pegmolesatide Product Picture
Figure 7. Global Long-acting ESAs Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Long-acting ESAs Market Share by Application: 2025 & 2032
Figure 9. Renal Anemia
Figure 10. Cancer
Figure 11. Other
Figure 12. Global Long-acting ESAs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Long-acting ESAs Market Size (US$ Million), 2021–2032
Figure 14. Global Long-acting ESAs Sales (K Units), 2021–2032
Figure 15. Global Long-acting ESAs Average Price (US$/Unit), 2021–2032
Figure 16. Long-acting ESAs Report Years Considered
Figure 17. Long-acting ESAs Sales Share by Manufacturers in 2025
Figure 18. Global Long-acting ESAs Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Long-acting ESAs Players: Market Share by Revenue in Long-acting ESAs in 2025
Figure 20. Long-acting ESAs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Long-acting ESAs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Long-acting ESAs Sales Market Share by Country (2021–2032)
Figure 23. North America Long-acting ESAs Revenue Market Share by Country (2021–2032)
Figure 24. United States Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Long-acting ESAs Sales Market Share by Country (2021–2032)
Figure 27. Europe Long-acting ESAs Revenue Market Share by Country (2021–2032)
Figure 28. Germany Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Long-acting ESAs Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Long-acting ESAs Revenue Market Share by Region (2021–2032)
Figure 35. China Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Long-acting ESAs Sales Market Share by Country (2021–2032)
Figure 43. Latin America Long-acting ESAs Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Long-acting ESAs Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Long-acting ESAs Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Long-acting ESAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Long-acting ESAs by Type (2021–2032)
Figure 54. Global Revenue Market Share of Long-acting ESAs by Type (2021–2032)
Figure 55. Global Long-acting ESAs Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Long-acting ESAs by Application (2021–2032)
Figure 57. Global Revenue Market Share of Long-acting ESAs by Application (2021–2032)
Figure 58. Global Long-acting ESAs Price (US$/Unit) by Application (2021–2032)
Figure 59. Long-acting ESAs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
